CD1B Antibodies

Santa Cruz Biotechnology offers a broad range of CD1B monoclonal antibodies for investigating CD1B's role in immune responses. CD1B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD1B is a member of the CD1 family of glycoproteins, which play a crucial role in the presentation of lipid antigens to T cells. CD1B functions in the recognition of non-peptide antigens, contributing to the immune system's ability to respond to a diverse array of pathogens. Understanding CD1B functionality is vital for advancing research in immunology and developing potential therapeutic strategies. CD1B monoclonal antibodies enable researchers to explore antigen presentation pathways and immune cell interactions. Investigating CD1B mechanisms provides valuable insights into immune system regulation and response patterns. CD1B research continues to reveal new aspects of lipid antigen presentation and T cell activation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of immune system dynamics and potential therapeutic applications.